Format

Send to

Choose Destination
See comment in PubMed Commons below
Pharmaceutics. 2011;3(2):186-228. doi: 10.3390/pharmaceutics3020186.

Design, Synthesis, and Biological Evaluation of PKD Inhibitors.

Author information

  • 1Department of Chemistry, University of Pittsburgh, Pittsburgh, PA 15260, USA.

Abstract

Protein kinase D (PKD) belongs to a family of serine/threonine kinases that play an important role in basic cellular processes and are implicated in the pathogenesis of several diseases. Progress in our understanding of the biological functions of PKD has been limited due to the lack of a PKD-specific inhibitor. The benzoxoloazepinolone CID755673 was recently reported as the first potent and kinase-selective inhibitor for this enzyme. For structure-activity analysis purposes, a series of analogs was prepared and their in vitro inhibitory potency evaluated.

PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for PubMed Central
    Loading ...
    Write to the Help Desk